Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Aug;85(16):6142–6146. doi: 10.1073/pnas.85.16.6142

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.

D L Garcia 1, S Anderson 1, H G Rennke 1, B M Brenner 1
PMCID: PMC281921  PMID: 3413082

Abstract

Chronic renal disease is frequently characterized by anemia, which may modify systemic and renal hemodynamics. In adult Munich-Wistar rats, the mild anemia (hematocrit, approximately equal to 42 vol/dl) that accompanies five-sixths nephrectomy was either made more severe (approximately equal to 30 vol/dl) by feeding a low iron diet or prevented (approximately equal to 50 vol/dl) by administration of recombinant human erythropoietin (r-HuEpo). In functional studies performed 4 weeks after renal ablation, untreated rats exhibited mild anemia with systemic hypertension and elevation of the single nephron glomerular filtration rate due to glomerular capillary hyperperfusion and hypertension. Preventing anemia with r-HuEpo worsened systemic and glomerular hypertension, effects largely obviated by induction of more marked anemia with the low iron diet. Untreated rats followed for 6 weeks postablation exhibited progressive proteinuria and sclerosis involving 12% of glomeruli, contrasted with 33% in rats given r-HuEpo. Even after 12 weeks, sclerosis involved only 6% of glomeruli in rats with more severe anemia but progressed to 30% in untreated rats. Thus, anemia limits systemic and glomerular hypertension and glomerular injury, whereas its prevention by r-HuEpo severely accelerates hemodynamically mediated glomerular injury in this model. These results suggest that anemia is a hemodynamically favorable adaptation to chronic renal disease and that its overly vigorous correction may have adverse renal hemodynamic and structural consequences.

Full text

PDF
6142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad R., Hand M. Recombinant erythropoietin for the anemia of chronic renal failure. N Engl J Med. 1987 Jul 16;317(3):169–170. doi: 10.1056/NEJM198707163170313. [DOI] [PubMed] [Google Scholar]
  2. Anderson S., Rennke H. G., Brenner B. M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986 Jun;77(6):1993–2000. doi: 10.1172/JCI112528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blantz R. C., Konnen K. S., Tucker B. J. Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest. 1976 Feb;57(2):419–434. doi: 10.1172/JCI108293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brenner B. M., Galla J. H. Influence of postglomerular hematocrit and protein concentration on rat nephron fluid transfer. Am J Physiol. 1971 Jan;220(1):148–161. doi: 10.1152/ajplegacy.1971.220.1.148. [DOI] [PubMed] [Google Scholar]
  5. Brenner B. M., Meyer T. W., Hostetter T. H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–659. doi: 10.1056/NEJM198209093071104. [DOI] [PubMed] [Google Scholar]
  6. Chien S. Blood rheology in myocardial infarction and hypertension. Biorheology. 1986;23(6):633–653. doi: 10.3233/bir-1986-23614. [DOI] [PubMed] [Google Scholar]
  7. DE WARDENER H. E., McSWINEY R. R., MILES B. E. Renal haemodynamics in primary polycythaemia. Lancet. 1951 Aug 4;2(6675):204–205. doi: 10.1016/s0140-6736(51)91442-0. [DOI] [PubMed] [Google Scholar]
  8. Deen W. M., Troy J. L., Robertson C. R., Brenner B. M. Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest. 1973 Jun;52(6):1500–1508. doi: 10.1172/JCI107324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Devereux R. B., Drayer J. I., Chien S., Pickering T. G., Letcher R. L., DeYoung J. L., Sealey J. E., Laragh J. H. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol. 1984 Sep 1;54(6):592–595. doi: 10.1016/0002-9149(84)90255-8. [DOI] [PubMed] [Google Scholar]
  10. Duke M., Abelmann W. H. The hemodynamic response to chronic anemia. Circulation. 1969 Apr;39(4):503–515. doi: 10.1161/01.cir.39.4.503. [DOI] [PubMed] [Google Scholar]
  11. Eschbach J. W., Egrie J. C., Downing M. R., Browne J. K., Adamson J. W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987 Jan 8;316(2):73–78. doi: 10.1056/NEJM198701083160203. [DOI] [PubMed] [Google Scholar]
  12. Garcia D. L., Rennke H. G., Brenner B. M., Anderson S. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J Clin Invest. 1987 Sep;80(3):867–874. doi: 10.1172/JCI113145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hostetter T. H., Meyer T. W., Rennke H. G., Brenner B. M. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int. 1986 Oct;30(4):509–517. doi: 10.1038/ki.1986.215. [DOI] [PubMed] [Google Scholar]
  14. Hostetter T. H., Olson J. L., Rennke H. G., Venkatachalam M. A., Brenner B. M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981 Jul;241(1):F85–F93. doi: 10.1152/ajprenal.1981.241.1.F85. [DOI] [PubMed] [Google Scholar]
  15. Kimura H., Finch C. A., Adamson J. W. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia. J Cell Physiol. 1986 Feb;126(2):298–306. doi: 10.1002/jcp.1041260221. [DOI] [PubMed] [Google Scholar]
  16. Letcher R. L., Chien S., Pickering T. G., Laragh J. H. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension. 1983 Sep-Oct;5(5):757–762. doi: 10.1161/01.hyp.5.5.757. [DOI] [PubMed] [Google Scholar]
  17. Letcher R. L., Chien S., Pickering T. G., Sealey J. E., Laragh J. H. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med. 1981 Jun;70(6):1195–1202. doi: 10.1016/0002-9343(81)90827-5. [DOI] [PubMed] [Google Scholar]
  18. MURRAY J. F., GOLD P., JOHNSON B. L., Jr The circulatory effects of hematocrit variations in normovolemic and hypervolemic dogs. J Clin Invest. 1963 Jul;42:1150–1159. doi: 10.1172/JCI104800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Maddox D. A., Price D. C., Rector F. C., Jr Effects of surgery on plasma volume and salt and water excretion in rats. Am J Physiol. 1977 Dec;233(6):F600–F606. doi: 10.1152/ajprenal.1977.233.6.F600. [DOI] [PubMed] [Google Scholar]
  20. McDonald K. M. Effect of hematocrit and colloid-induced changes in blood viscosity on renal hemodynamics and renin release in the dog. Circ Res. 1974 Jan;34(1):112–122. doi: 10.1161/01.res.40.4.112. [DOI] [PubMed] [Google Scholar]
  21. McGonigle R. J., Wallin J. D., Shadduck R. K., Fisher J. W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984 Feb;25(2):437–444. doi: 10.1038/ki.1984.36. [DOI] [PubMed] [Google Scholar]
  22. Myers B. D., Deen W. M., Robertson C. R., Brenner B. M. Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit. Circ Res. 1975 Mar;36(3):425–435. doi: 10.1161/01.res.36.3.425. [DOI] [PubMed] [Google Scholar]
  23. Nashat F. S., Portal R. W. The effects of changes in haematocrit on renal function. J Physiol. 1967 Dec;193(3):513–522. doi: 10.1113/jphysiol.1967.sp008375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nashat F. S., Scholefield F. R., Tappin J. W., Wilcox C. S. The effects of changes in haematocrit on the intrarenal distribution of blood flow in the dog's kidney. J Physiol. 1969 May;201(3):639–655. doi: 10.1113/jphysiol.1969.sp008777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Neff M. S., Kim K. E., Persoff M., Onesti G., Swartz C. Hemodynamics of uremic anemia. Circulation. 1971 Jun;43(6):876–883. doi: 10.1161/01.cir.43.6.876. [DOI] [PubMed] [Google Scholar]
  26. Norris S. H., Kurtzman N. A. Minimizing anemia in the chronic hemodialysis patient. Int J Artif Organs. 1986 Jul;9(4):199–206. [PubMed] [Google Scholar]
  27. Pfeffer J. M., Pfeffer M. A., Frohlich E. D. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med. 1971 Dec;78(6):957–962. [PubMed] [Google Scholar]
  28. Raine A. E. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet. 1988 Jan 16;1(8577):97–100. doi: 10.1016/s0140-6736(88)90293-0. [DOI] [PubMed] [Google Scholar]
  29. SPEAR G. S. Glomerular alterations in cyanotic congenital heart disease. Bull Johns Hopkins Hosp. 1960 Jun;106:347–367. [PubMed] [Google Scholar]
  30. SPEAR G. S. THE GLOMERULUS IN CYANOTIC CONGENITAL HEART DISEASE AND PRIMARY PULMONARY HYPERTENSION. A REVIEW. Nephron. 1964;1:238–248. doi: 10.1159/000179337. [DOI] [PubMed] [Google Scholar]
  31. Schrier R. W., Earley L. E. Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest. 1970 Sep;49(9):1656–1667. doi: 10.1172/JCI106383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Simchon S., Chen R. Y., Carlin R. D., Fan F. C., Jan K. M., Chien S. Effects of blood viscosity on plasma renin activity and renal hemodynamics. Am J Physiol. 1986 Jan;250(1 Pt 2):F40–F46. doi: 10.1152/ajprenal.1986.250.1.F40. [DOI] [PubMed] [Google Scholar]
  33. Sklar A. H., Chaudhary B. A. Reversible proteinuria in obstructive sleep apnea syndrome. Arch Intern Med. 1988 Jan;148(1):87–89. [PubMed] [Google Scholar]
  34. Viets J. W., Deen W. M., Troy J. L., Brenner B. M. Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem. 1978 Aug 1;88(2):513–521. doi: 10.1016/0003-2697(78)90451-7. [DOI] [PubMed] [Google Scholar]
  35. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  36. Wilcox C. S., Payne J., Harrison B. D. Renal function in patients with chronic hypoxaemia and cor pulmonale following reversal of polycythaemia. Nephron. 1982;30(2):173–177. doi: 10.1159/000182456. [DOI] [PubMed] [Google Scholar]
  37. Zatz R., Dunn B. R., Meyer T. W., Anderson S., Rennke H. G., Brenner B. M. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986 Jun;77(6):1925–1930. doi: 10.1172/JCI112521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zatz R., Meyer T. W., Rennke H. G., Brenner B. M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5963–5967. doi: 10.1073/pnas.82.17.5963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. de Jong P. E., Weening J. J., Donker A. J., van der Hem G. K. The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease. Nephron. 1983;33(3):225–226. doi: 10.1159/000182948. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES